Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.61

-0.6%

Nov 6 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (530)	1/23/2000 9:11:00 AM
From: biowa	Read Replies (4) of 52153

PB, Tossing out a random thought that will probably get lost in the rally: At what point does the sum total of future revenue streams (admittedly 5-10 years out in some cases) implied by combined biotech, pharma, med device and other med technology market caps exceed a reasonable expectation for US or even global health spending? Depressed pharma prices in 1999 may have provided some room, but... Not that anyone cares about revenues right now, but I thought I'd book mark it for later. biowa

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next